Work

Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator

Year: 2004

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-04-1084

Authors: Jennifer E. Sprague, Yijie Peng, Xiankai Sun, Gary R. Weisman, Edward H. Wong, Samuel Achilefu, Carolyn J. Anderson

Institutions: Washington University in St. Louis, University of New Hampshire

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Institute of General Medical Sciences

Awards: Radiopharmaceuticals based on Cross-bridged Ligands, Washington University Small Animal Imaging Resource, Radionuclide Resource for Cancer Applications, G293740201, G4059150900, G5764213625, RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY, G665431127, Novel Monomolecular Multi Modality Imaging Agents, National Research Service Award-Medical Scientist, G798521692

OpenAlex ID: W2116290973

FWCI: 8.939

Cites: 46

Cited by: 158

Related to: 10